[HTML][HTML] Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera

T Tada, H Zhou, BM Dcosta, MI Samanovic… - Iscience, 2021 - cell.com
Highly transmissible SARS-CoV-2 variants identified in India and designated B. 1.617,
Kappa (B. 1.617. 1), Delta (B. 1.617. 2), B. 1.618, and B. 1.36. 29 contain spike mutations …

The spike proteins of SARS-CoV-2 B. 1.617 and B. 1.618 variants identified in India provide partial resistance to vaccine-elicited and therapeutic monoclonal …

T Tada, H Zhou, BM Dcosta, MI Samanovic… - BioRxiv, 2021 - biorxiv.org
Highly transmissible SARS-CoV-2 variants recently identified in India designated B. 1.617
and B. 1.618 have mutations within the spike protein that may contribute to their increased …

[HTML][HTML] SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced …

SN Neerukonda, R Vassell, S Lusvarghi, R Wang… - Viruses, 2021 - mdpi.com
The SARS-CoV-2 B. 1.617 lineage variants, Kappa (B. 1.617. 1) and Delta (B. 1.617. 2, AY)
emerged during the second wave of infections in India, but the Delta variants have become …

[HTML][HTML] The impact on infectivity and neutralization efficiency of SARS-CoV-2 lineage B. 1.351 pseudovirus

YJ Kim, US Jang, SM Soh, JY Lee, HR Lee - Viruses, 2021 - mdpi.com
A new variant of SARS-CoV-2 B. 1.351 lineage (first found in South Africa) has been raising
global concern due to its harboring of multiple mutations in the spike that potentially …

[HTML][HTML] Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization

H Guo, Q Fan, S Song, S Shen, B Zhou, H Wang… - Journal of Clinical …, 2022 - Elsevier
A recently identified SARS-CoV-2 variant, Lambda, has spread to many countries around
the world. Here, we measured and evaluated the reduced sensitivity of Lambda variant to …

[HTML][HTML] Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation

X Deng, MA Garcia-Knight, MM Khalid, V Servellita… - MedRxiv, 2021 - ncbi.nlm.nih.gov
We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172
nasal/nasopharyngeal swab samples from 44 counties in California. Named B. 1.427/B …

[HTML][HTML] Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

X Deng, MA Garcia-Knight, MM Khalid, V Servellita… - Cell, 2021 - cell.com
We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples …

SARS-CoV-2 lambda variant remains susceptible to neutralization by mRNA vaccine-elicited antibodies and convalescent serum

T Tada, H Zhou, BM Dcosta, MI Samanovic… - BioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 lambda variant (lineage C. 37) was designated by the World Health
Organization as a variant of interest and is currently increasing in prevalence in South …

[HTML][HTML] Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

D Planas, D Veyer, A Baidaliuk, I Staropoli… - Nature, 2021 - nature.com
Abstract The SARS-CoV-2 B. 1.617 lineage was identified in October 2020 in India,,,–. Since
then, it has become dominant in some regions of India and in the UK, and has spread to …

[HTML][HTML] SARS-CoV-2 501Y. V2 variants lack higher infectivity but do have immune escape

Q Li, J Nie, J Wu, L Zhang, R Ding, H Wang, Y Zhang… - Cell, 2021 - cell.com
The 501Y. V2 variants of SARS-CoV-2 containing multiple mutations in spike are now
dominant in South Africa and are rapidly spreading to other countries. Here, experiments …